Regeneron

$473.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$23.85 (+5.31%) As of 3:33 PM EDT today
+$23.85 (+5.31%) Today

Why Robinhood?

You can buy or sell Regeneron and other stocks, options, ETFs, and crypto commission-free!

About REGN

Regeneron Pharmaceuticals, Inc. Common Stock, also called Regeneron, is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Read More It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Employees
8,100
Headquarters
Tarrytown, New York
Founded
1988
Market Cap
47.28B
Price-Earnings Ratio
24.35
Dividend Yield
—
Average Volume
2.16M
High Today
$476.10
Low Today
$461.00
Open Price
$463.09
Volume
1.06M
52 Week High
$518.00
52 Week Low
$271.37

Collections

REGN News

CNBC3h

Stocks making the biggest moves midday: Johnson & Johnson, Eldorado Resorts, Regeneron & more

Check out the companies making headlines midday Monday: Johnson & Johnson — Johnson & Johnson shares jumped more than 7% after the company announced it has a c
196
Benzinga4h

Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol

TARRYTOWN, N.Y., March 30, 2020 /PRNewswire/ -- Results from separate positive Phase 3 trial of Praluent® (alirocumab) in patients with HoFH also presented; FD
295
MarketWatch8h

First patient treated in Regeneron, Sanofi trial for COVID-19 treatment

Regeneron Pharmaceuticals Inc. REGN, -0.61% and Sanofi SA SNY, -1.19% said Monday that the first patient in a global clinical trial testing Kevzara as a therapy
1,126

REGN Earnings

$0.00
$2.50
$5.00
$7.50
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, Pre-Market

People Also Bought

You May Also Like

More REGN News

CNBCMar 27

Developing a vaccine takes 10 years. Sanofi seeks to do so within 18 months

The process to develop a vaccine typically takes a decade, but an untypical circumstance is calling for it to be done in a fraction of the time, the head of a F
904
BloombergMar 26

Regeneron Says FDA Moving Quickly on Potential Coronavirus Treatments

Mar.26 -- Dr. George Yancopoulos, Regeneron co-founder and chief scientific officer, talks about how the company is working with the FDA to find treatments for
1,174
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.